Rad's alleged involvement in peddling date rape drug lands him behind bars

A radiologist in Miami has been arrested for allegedly peddling “date rape” drugs, according to multiple news outlets local to the matter. 

Dairon Garcia, MD, is a radiologist and assistant professor at the University of Miami's Miller School of Medicine. He was arrested Thursday for allegedly helping to traffic gamma-butyrolactone (GBL)—a common date rape drug. 

According to police reports, federal authorities became suspicious of Garcia after a package containing around 15 pounds of GBL, also known as “liquid ecstasy,” was intercepted by customs at Miami International Airport in late August. The package was mailed from a French address to a duplex in Miami. Authorities were on standby when the package was delivered, and after the woman living at the residence picked the delivery up from her front door, the duplex was raided. 

The woman informed authorities that the package was for the owner of the duplex, that she had been told it would be arriving and asked to “receive the package.” Another resident at the duplex had a similar story, saying that they had also received a package that Garcia, the owner of the property, later picked up. 

The items were addressed to two entities—"Damaga Properties" and "DG Diagnostics MD LLC." The property manager claimed that she did not know why Garcia was having packages mailed to the residents, only to later pick them up himself.  

Garcia appeared in court Friday, where Miami-Dade Judge Mindy Glazer did not mince words. 

“He should be so embarrassed being here,” Glazer said. “He’s a medical doctor, going through all those years of education and committing his life to helping people and to get arrested for this—that’s between you, your lawyer and the criminal justice system. Good luck to you, sir.” 

Garcia was released from jail Friday evening. 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.